Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02979054
Other study ID # LT4020-302
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 2016
Est. completion date March 2018

Study information

Verified date October 2019
Source Laboratoires Thea
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess the performance and safety of T4020 versus saline solution.


Recruitment information / eligibility

Status Completed
Enrollment 157
Est. completion date March 2018
Est. primary completion date March 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adult patients diagnosed with progressive keratoconus

- Patients who signed and dated informed consent

Exclusion Criteria:

- Patient under 18 years

- History within 1 month or any active ocular infection, ocular injury, and associated corneal ulceration and abscess

- Corneal thickness< 400µm

Study Design


Related Conditions & MeSH terms


Intervention

Device:
T4020

Placebo


Locations

Country Name City State
Bulgaria Hospital Varna
France CHU Clermont Ferrand
Spain Hospital Vigo
Turkey Erciyes Üniversitesi Tip Fakültesi Kayseri

Sponsors (1)

Lead Sponsor Collaborator
Laboratoires Thea

Countries where clinical trial is conducted

Bulgaria,  France,  Spain,  Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Participants With Complete Healing of Corneal Epithelial Defect at Day 3 Day 3
Primary Number of Participants With Complete Healing of Corneal Epithelial Defect at Day 4 Day 4
Secondary Corneal Epithelial Defect Size Assessment Baseline and Day 5
Secondary Number of Participants With Treatment-emergent Adverse Events Through study completion, an average of 1 month
See also
  Status Clinical Trial Phase
Recruiting NCT04570020 - Scleral Lens Fitting Using Wide-Field OCT
Recruiting NCT02921009 - McNeel Eye Center Corneal Crosslinking Study N/A
Completed NCT01691651 - Botulinum Toxin A for the Treatment of Keratoconus N/A
Terminated NCT02762253 - Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus. Phase 2
Completed NCT01527708 - Accuracy of Curvature and Wavefront Aberrations of Posterior Corneal Surface, in Keratoconic and Post-CXL Corneas N/A
Completed NCT01527721 - Blurring Strength & Aberrometric Changes Following Corneal Cross-linking (CxL) and CxL Combined With Photorefractive Keratectomy (PRK) in Keratoconus N/A
Recruiting NCT00841386 - Treatment of Keratoconus Using Collagen Cross-Linking Phase 2/Phase 3
Completed NCT00347074 - A Clinical Study of Keratoconus in Asian Patients and Assessment of Different Topographic Patterns of Keratoconus in Asian Patients N/A
Completed NCT03187912 - Accelerated Corneal Cross-linking With Different Riboflavin Solutions Phase 3
Completed NCT00584285 - Corneal Topographer Fluorescein Patterns
Completed NCT03511495 - Reliability of Topography Measurements in Keratoconus
Not yet recruiting NCT05395650 - Cyanocobalamin as Photosensitizing Agent
Completed NCT04418999 - Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus Early Phase 1
Completed NCT03235856 - Retrospective Digital Computer Analysis of Keratoconus Evolution - REDCAKE
Completed NCT05019768 - Topo-pachimetric Accelerated Epi-On Cross-linking Compared to Dresden Protocol Using Riboflavin With Vitamin E TPGS N/A
Withdrawn NCT01789333 - Higher Irradiance in Keratoconus Ectasia N/A
Completed NCT05114928 - Correlation Between Q-value Changes and Progression of Pediatric Keratoconus.
Completed NCT03647046 - Custom Anterior Surfacing of Scleral Lens for Vision Quality Improvement in Patients With Keratoconus N/A
Recruiting NCT04439552 - fMRI and IVCM Cornea Microscopy of CXL in Keratoconus
Recruiting NCT06100939 - Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus Phase 3